Literature DB >> 1693385

Constitutive absence and interferon-gamma-induced expression of adhesion molecules in basal cell carcinoma.

R S Taylor1, C E Griffiths, M D Brown, N A Swanson, B J Nickoloff.   

Abstract

Adhesion of lymphocytes to target cells via certain cell surface molecules is important in cytotoxic T lymphocyte-mediated immune reactions. The binding of lymphocyte function-associated (LFA) antigens 1 and 2, with their respective ligands, intercellular adhesion molecule-1 (ICAM-1) and LFA-3, which are expressed on the surface of nonlymphoid cells, has been shown to be critical for lymphocyte adhesion. To determine whether basal cell carcinomas (BCCs) can escape immunodetection as a result of the inability of cytotoxic T lymphocytes to bind tumor cells, the expression of adhesion molecules on numerous BCCs, before and after exposure to interferon-gamma (IFN-gamma), was examined. Ninety-three percent of 30 freshly excised invasive BCCs did not express ICAM-1 and 73% of 11 BCCs did not express LFA-3. However, the normal-appearing basal keratinocytes in epidermis overlying nests of BCC, did express ICAM-1, particularly when a marked LFA-1+ and LFA-2+ dermal lymphocytic infiltrate was present. After BCC tissue was incubated in vitro with IFN-gamma the expression of ICAM-1 was induced on 85% of tumors studied. Thus tumor cells did not possess an absolute inability to express adhesion molecules; rather the constitutive absence of such molecules may be due to insufficient in vivo cytokine levels necessary to induce expression or a barrier preventing cytokines from reaching and interacting with tumor cells. We conclude that the absence of ICAM-1 and LFA-3 adhesion molecules is a mechanism by which BCCs can avoid immunosurveillance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693385     DOI: 10.1016/0190-9622(90)70097-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).

Authors:  C Gutierrez-Steil; T Wrone-Smith; X Sun; J G Krueger; T Coven; B J Nickoloff
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

2.  Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro.

Authors:  T Takahashi; H Ishikura; K Iwai; C Takahashi; H Kato; T Tanabe; T Yoshiki
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells.

Authors:  W Dippold; B Wittig; W Schwaeble; W Mayet; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

4.  Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo.

Authors:  T Wrone-Smith; T Johnson; B Nelson; L H Boise; C B Thompson; G Núñez; B J Nickoloff
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

Review 5.  Adhesion Molecules in Non-melanoma Skin Cancers: A Comprehensive Review.

Authors:  Joanna Pogorzelska-Dyrbus; Jacek C Szepietowski
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

6.  Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.

Authors:  Lorraine O'Driscoll; Jason McMorrow; Padraig Doolan; Eadaoin McKiernan; Jai Prakash Mehta; Eoin Ryan; Patrick Gammell; Helena Joyce; Norma O'Donovan; Nicholas Walsh; Martin Clynes
Journal:  Mol Cancer       Date:  2006-12-15       Impact factor: 27.401

7.  Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells.

Authors:  Sandra Laner-Plamberger; Florian Wolff; Alexandra Kaser-Eichberger; Stefan Swierczynski; Cornelia Hauser-Kronberger; Anna-Maria Frischauf; Thomas Eichberger
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

8.  Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Zorica Janjetovic; Allen S W Oak; Arnold Postlethwaite; Zongtao Lin; Wei Li; Yukimasa Takeda; Anton M Jetten; Robert C Tuckey
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.